<DOC>
	<DOCNO>NCT01328808</DOCNO>
	<brief_summary>The purpose study investigate acetaminophen ( APAP ) release urine blood ; determine blood level acetaminophen breakdown product affect preterm infant 's health ; decrease adverse drug reaction ; collect data genetic make-up characteristic affect APAP handle within preterm infant . By take several blood urine sample study , able check blood level ( call pharmacokinetics ) APAP preterm baby .</brief_summary>
	<brief_title>Metabolism Toxicity Acetaminophen</brief_title>
	<detailed_description>Study procedure : The decision replace standard intravenous morphine therapy APAP make attend neonatologist . Length participation : 60 hour . No patient prescribed medication specifically study purpose study protocol .</detailed_description>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Preterm term neonates gender race postnatal age le 28 day GA 's 22 le 37 week indwell ( peripheral umbilical ) arterial line clinical indication intravenous administration pain relief medication Neonates severe asphyxia grade III IV intraventricular hemorrhage , major congenital malformations/facial malformation ( e.g. , cleave lip palate ) , neurological disorder receive continuous intermittent neuromuscular blocker clinical biochemical evidence hepatic renal failure ( include systemic hypoperfusion )</criteria>
	<gender>All</gender>
	<minimum_age>22 Weeks</minimum_age>
	<maximum_age>37 Weeks</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Acetaminophen</keyword>
	<keyword>Preterm Infants</keyword>
</DOC>